Abstract
This study presents a 57-year-old male patient with COVID-19 who had had
no lung disease before COVID-19 pneumonia. However, after COVID-19
pneumonia with sequels and treatments that include corticosteroids and
IL-6 receptor antagonists, an invasive pulmonary aspergillus (IPA)
cavity occurred immediately.